Participants 256 293 5
patients with operable gastric cancer
Participants 496 753 6
Patients younger than 75 years of age with a good physical and mental condition and a histologically proven adenocarcinoma of the stomach without clinical or radiographic (computed tomography scan) evidence of distant metastases were eligible for this trial
Participants 755 810 3
Early gastric cancer or cardia carcinoma were excluded.
Participants 1259 1389 5
56 eligible and evaluable patients were entered: 27 were randomised to receive FAMTX before surgery and 29 to undergo surgery only
